The technology provides urologists with real-time ultrasound imaging, magnetic resonance imaging and 3D-visualized biopsy data while navigating the cancerous tumor, according to a July 10 press release from Cottage Health.
The combination of these technologies allows for precise targeting and removal of the cancerous area, enabling a smaller portion of the prostate to be ablated without making incisions. Removing a smaller portion of tissue minimizes the damage to the surrounding healthy tissue and the risk of negative side effects, according to the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
